Ron Bose, MD, PhD

Clinical Expertise

As a member of our breast cancer specialist team, Dr. Bose cares for patients diagnosed with breast cancer through treatment and recovery. Learn more about how Dr. Bose and Siteman approach breast cancer diagnosis and staging, treatment and recovery.

Research Interest

HER2-positive breast cancer is a subtype of breast cancer where the HER2/neu tyrosine kinase drives the proliferation of cancer cells by activating a biochemical signaling pathway. We study this pathway using the techniques of proteomics and mass spectometry, coupled with traditional biochemistry and cell biology approaches.

Education

• 1998: PhD, pharmacology and biochemistry, Cornell University, New York
• 1999: MD, Cornell University

Training

• 1999 - 2002: Intern and resident, internal medicine, Washington University, St. Louis
• 2002 - 2007: Fellow, medical oncology, Johns Hopkins University, Baltimore, Md.

Board Certification

• 2002: American Board of Internal Medicine, Internal Medicine
• 2004: American Board of Internal Medicine, Medical Oncology

Selected Research Publications